This publication examines the innovation system in pharmaceutical biotechnology in eight OECD countries - Belgium …, Finland, France, Germany, Japan, the Netherlands, Norway and Spain. The report summarises the results of in-depth studies …, providing a comparative analysis of participating countries' performance in science and innovation in biopharmaceuticals. It …

What are the specific characteristics of innovation in pharmaceutical biotechnology? How do biopharmaceutical … innovation systems in OECD countries perform and which policies are suitable to foster performance?. This publication examines … the innovation system in pharmaceutical biotechnology in eight OECD countries - Belgium, Finland, France, Germany, Japan …

assesses the current status of Norway’s innovation system and policies, and identifies where and how the government should … a shift towards knowledge-based activities for which innovation is the key determinant of competitiveness. This report … focus its efforts to improve the country's innovation capabilities. …

Norway is a test-bed for the implementation of a bold vision of lifelong learning. There is broad and strong political … support within Norway for lifelong learning as a next logical step for a highly developed country with a highly educated … shortages and increased leisure time, and an increasingly diverse society. But even in Norway the institutional arrangements and …

OECD countries and tailors it to the context of an OECD country: Norway. Despite diversity in provision across countries … student attainment in this level (or to make this level more effective) in Norway. …

Following a remarkable transformation in the past century in research and innovation, in particular through the …, Norway is today increasingly facing a “triple transition imperative” in which it needs, first, to shift toward a more … diversified and robust economy; second, to move to a more competitive, effective and efficient innovation system; and third, to …